Concepedia

Author

Cheng Peng

Qilu Hospital of Shandong UniversityORCID

Also Known As

Cheng Peng, P. Cheng, Peng Cheng, Peng, Cheng

26

Publications

496

Citations

12

H-Index

22

Concepts

All Affiliations

Qilu Hospital of Shandong UniversityFirst Affiliated Hospital of GuangXi Medical UniversityGuangxi Medical UniversityThird Xiangya HospitalCentral South University
CP

About

Cheng Peng is an author at Qilu Hospital of Shandong University specializing in medicine, immunology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

201

2

Immunology

4

4

142

3

Cell Biology

3

3

144

4

Health Sciences

1

1

24

5

Pathology

1

1

62

Cheng Peng

×

12

Publications

472

Citations

12

H-Index

YearCitations

SDF-1/CXCR4 axis promotes directional migration of colorectal cancer cells through upregulation of integrin αvβ6

Ben Wang, Wenke Wang, Weibo Niu,

Carcinogenesis

2013

66

A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia

Heng Mei, Xiaofan Liu, Yan Li,

Journal of Hematology & Oncology

2021

66

Interleukin-8 promotes cell migration through integrin αvβ6 upregulation in colorectal cancer

Qi Sun, Fengkai Sun, Ben Wang,

Cancer Letters

2014

62

The β6-integrin-ERK/MAP kinase pathway contributes to chemo resistance in colon cancer

Song Liu, Jian Wang, Weibo Niu,

Cancer Letters

2012

59

Integrin αvβ6 plays a bi-directional regulation role between colon cancer cells and cancer-associated fibroblasts

Cheng Peng, Xueqing Zou, Wanying Xia,

Bioscience Reports

2018

50

Induction of leukotriene B4 and prostaglandin E2 release from keratinocytes by protease-activated receptor-2-activating peptide in ICR mice

Yu Zhu, Xiao Rong Wang, Cheng Peng,

International Immunopharmacology

2009

33

Integrin β6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway in pancreatic ductal adenocarcinoma (PDAC)

Zequn Li, Pengfei Lin, Chao Gao,

Tumor Biology

2015

30

Suppression of integrin αυβ6 by RNA interference in colon cancer cells inhibits extracellular matrix degradation through the MAPK pathway

Jiayong Wang, Zhaoyang Zhang, Kesen Xu,

International Journal of Cancer

2008

24

Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study

Yu Hu, Xiaofan Liu, Hu Zhou,

The Lancet Haematology

2024

24

[The effect of mangiferin on telomerase activity and apoptosis in leukemic K562 cells].

Cheng Peng, Zhigang Peng, Jie Yang,

PubMed

2007

23

Page 1